Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00091559
Status:
COMPLETED
Last Update Posted:
2017-04-05
First Post:
2004-09-10
Brief Title:
Oral SAHA Suberoylanilide Hydroxamic Acid in Advanced Cutaneous T-cell Lymphoma 0683-001
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-02-03
Start Date Type:
ACTUAL
Primary Completion Date:
2005-11-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-10
First Submit QC Date:
September 13 2004
Study First Post Date:
2004-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-03
Last Update Post Date:
2017-04-05
Last Update Post Date Type:
ACTUAL